Stock Information for ATYR
Overview of ATYR
ATYR, also known as aTyr Pharma Inc, is a company in the Health Care sector. aTyr Pharma Inc's website is https://www.atyrpharma.com.
Market Capitalization
ATYR has a market cap of $250.99 million with 83,942,407.00 shares outstanding as of Tue, Nov 5, 2024.
Stock Charts
The ATYR stock charts offer a comprehensive, real-time view of aTyr Pharma Inc's stock performance. Powered by TradingView, these interactive charts provide investors with a dynamic and detailed visualization of ATYR's market activity.
Key features of the ATYR stock charts include:
- Real-Time Data: Get up-to-the-minute updates on aTyr Pharma Inc's stock price, ensuring you have the latest information at your fingertips.
- Customizable Time Frames: Analyze ATYR's performance over various periods, from intraday movements to long-term trends. Easily switch between daily, weekly, monthly, and yearly views.
- Technical Indicators: Utilize a wide array of technical indicators, such as moving averages, RSI, MACD, and more, to perform in-depth analysis of ATYR's stock movements.
- Drawing Tools: Enhance your analysis with TradingView's extensive drawing tools. Add trend lines, channels, Fibonacci retracements, and other annotations to your charts.
- Comparative Analysis: Compare ATYR's performance against other stocks, indices, or financial instruments to gain a broader market perspective.
- User-Friendly Interface: The interactive nature of the charts allows you to zoom in, pan across different periods, and hover over data points for detailed information, making it easy to track and analyze ATYR's stock performance.
Whether you're a day trader looking for quick insights or a long-term investor analyzing market trends, the ATYR stock charts provide all the tools you need to make informed decisions. Dive into the data and explore how aTyr Pharma Inc is performing in the market today.
Comprehensive Stock Forecast for ATYR
Understanding the future trajectory of a stock is crucial for investors, and ATYR is no exception. With numerous analysts and financial experts weighing in, it’s essential to have a comprehensive overview of what to expect. Below, we explore various aspects of the ATYR stock forecast, drawing insights from different time frames and sources to provide a well-rounded perspective.
The forecast for ATYR extends through multiple years, with detailed projections for 2024, 2025, 2029, 2034, and even as far as 2034. These projections are based on various factors, including market trends, financial health, and overall economic conditions. Notable sources such as FintechZoom, CNN Money, Zacks, and WalletInvestor offer diverse viewpoints, ensuring that investors get a holistic understanding of the potential growth or decline of ATYR.
In the short term, predictions for ATYR in the upcoming months or years (2024, 2025, 2029) are often influenced by current market performance and recent financial reports. For the long term, forecasts for 2029, 2034, and beyond consider broader economic indicators and industry trends. Analysts also provide specific outlooks, like the 5-year forecast, to help investors plan their strategies accordingly.
Moreover, platforms like CNBC and Yahoo Finance provide detailed analysis and expert opinions that contribute significantly to the stock’s forecast. Whether you’re looking for tomorrow’s prediction or the long-term outlook, these insights are invaluable. By examining forecasts from various credible sources, investors can make informed decisions based on a well-rounded view of the potential future of ATYR.
ATYR Dividend History
Discover the detailed dividend history for ATYR. This section provides an overview of the dividends distributed by aTyr Pharma Inc over the years. You'll find information on payout dates, dividend amounts, and historical dividend yield, helping you understand the company's track record of returning value to its shareholders.
ATYR Stock Split History
Explore the stock split history for ATYR. In this section, you will find detailed records of all stock splits undertaken by aTyr Pharma Inc. Understand how each split has affected the stock's price and share count, providing insights into the company's growth and strategies to make shares more affordable for investors.